June 10, 2004
Campbell Alliance, a management consulting firm specializing in the pharmaceutical and biotech industries, announced today that Gary Kirby has joined its Executive Advisory Group. The group is a team of industry professionals established by John Campbell, president of Campbell Alliance, to bring special expertise to bear on highly complex engagements. Mr. Kirby will focus on business development issues, working closely with Campbell Alliance’s Business Development Practice.
Mr. Kirby has a distinguished professional history in the pharmaceutical industry. Before joining Campbell Alliance, Mr. Kirby was vice president of Commercial Alliances and Worldwide Business Development at GlaxoSmithKline. In that role, he was responsible for global co-marketing, co-promotion, and late-stage activities for many of the company’s products. Prior to that, he was with Glaxo Wellcome and Glaxo Inc., serving as vice president, US Business Development and vice president, Business Sector Operations.
At Campbell Alliance, Mr. Kirby will be working closely with Nader Naeymi-Rad, senior vice president in charge of the firm’s Business Development Practice. “We are extremely pleased that Gary has joined our team,” said John Campbell, CEO of Campbell Alliance. “He brings over 30 years of experience in the pharmaceutical industry to his position, along with vast commercial knowledge encompassing marketing, sales, and business development. This depth of expertise is an invaluable resource for Campbell Alliance and our clients.”
Mr. Campbell plans to expand the Executive Advisory Group as additional opportunities to retain highly respected industry professionals with valuable expertise arise. “We’re always broadening our capabilities to enhance client service,” Campbell explained. “As we find other professionals who can offer Gary’s level of insight in other key service areas, such as Sales and Brand Management, we will increase the size of the group.”
Campbell Alliance boasts a clientele that includes the world’s leading pharmaceutical and biotech companies. It currently has offices in Raleigh, NC, and Parsippany, NJ. The firm serves clients throughout the US, Europe, and Japan.